DEF: Exicure Sets Dec 2, 2026 Meeting for Director Elections, Equity Plan

Exicure, Inc. has announced its 2026 Annual and Special Meeting of Stockholders to be held virtually on December 2, 2026, with key proposals including director elections, auditor ratification, a share issuance authorization, an equity incentive plan, and a charter amendment to increase authorized shares.

Summary

• Exicure, Inc. is holding its 2026 Annual and Special Meeting of Stockholders virtually on December 2, 2026.
• The meeting agenda includes electing two Class III directors, ratifying CBIZ CPAs P.C. as the independent auditor for fiscal year 2026, approving the issuance of over 20% of common stock in future private financings, adopting a 2026 omnibus equity incentive plan, and amending the charter to double authorized common stock from 200 million to 400 million shares.
• Stockholders of record as of November 3, 2026, are eligible to vote.
• The company is seeking authorization for private financings up to $10 million, potentially issuing units of one share and three warrants.
• The proposed 2026 Omnibus Incentive Plan reserves 981,899 shares, with annual increases tied to outstanding shares.
• The increase in authorized shares aims to support future capital needs, equity compensation, and strategic transactions.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily focused on procedural matters for an upcoming annual meeting, with proposals aimed at maintaining operational flexibility and future growth potential.

Positives

• The company is proactively planning for future capital needs and strategic initiatives through proposals for share issuance authorization and an increase in authorized shares.
• The adoption of a new 2026 Omnibus Incentive Plan aims to attract, retain, and motivate key personnel by aligning their interests with stockholders.
• The ratification of the independent auditor is a standard procedural step that supports financial transparency.
• The virtual meeting format aims to enhance stockholder access and participation.

Negatives

• The proposed share issuance for up to $10 million could result in substantial dilution to existing stockholders, especially if issued at a discount (75% of Nasdaq Minimum Price).
• The increase in authorized shares from 200 million to 400 million, while providing flexibility, significantly increases potential dilution for existing shareholders.
• The company is subject to Nasdaq Listing Rule 5635(d) for the share issuance proposal, indicating potential financial pressures or a need for capital.
• Several directors and executive officers have recently resigned or changed roles, suggesting potential instability or ongoing restructuring.

Risks

• Potential for significant dilution to existing shareholders due to the proposed share issuance and the doubling of authorized shares.
• The company's reliance on future private financing transactions to raise capital, as indicated by Proposal 3, suggests ongoing funding needs.
• The potential for anti-takeover effects from the increased number of authorized shares.
• The need to comply with Nasdaq Listing Rules for share issuances highlights the importance of maintaining exchange compliance.
• The company's transitional state and recent board turnover could pose governance or strategic execution risks.

Future Outlook

The company is seeking authorization for private financings up to $10 million and an increase in authorized shares to support future capital requirements, working capital, operating expenses, repayment of obligations, strategic investments, and general corporate purposes. The adoption of the 2026 Omnibus Incentive Plan is intended to support future business strategy and attract/retain talent.

Management Comments

• The Board of Directors believes that maintaining access to capital is critical to supporting the Company's business strategy, working capital requirements, corporate initiatives, and ongoing operations.
• The Board of Directors believes that stock-based incentive awards play an important role in the success of our company by encouraging and enabling the employees, officers, non-employee directors, and consultants of our company and its affiliates upon whose judgment, initiative and efforts our company largely depends for the successful conduct of its business to acquire a proprietary interest in our company.
• The Board of Directors believes that unless we obtain stockholder approval to amend the Charter to increase the number of authorized shares of common stock, we will be severely limited by the inability to issue additional shares in connection with future capital raising transactions, strategic transactions, awards under our equity compensation plans and other corporate purposes.

Industry Context

StockSavvy.ai notes that Exicure's proposals are common for companies seeking to maintain financial flexibility and incentivize employees, particularly in the biotechnology or pharmaceutical sectors where capital-intensive development and talent acquisition are crucial. The Nasdaq listing rule compliance for share issuance is a standard consideration for growth-oriented companies.

Comparison to Industry Standards

• The proposed 2026 Omnibus Incentive Plan, reserving 15% of outstanding shares (981,899 shares out of ~6.5 million outstanding as of Oct 27, 2026), is within typical ranges for companies of similar size and stage, aiming to align employee interests with shareholder value.
• The proposal to double authorized shares from 200 million to 400 million is a significant increase, but companies in capital-intensive industries often seek substantial authorized share pools to accommodate future financings and strategic needs without frequent shareholder votes.
• The structure of the proposed financing units (one share + three warrants) is a common instrument in private placements, often used to enhance investor returns and provide downside protection through the warrants.

Management Changes

Corporate Governance

Related Party Transactions

• Paul Kang Consulting Agreement: Alta Companies Ltd. (controlled by Mr. Kang) provided consulting services for corporate development, capital raising, and M&A, receiving $99,000 initial payment and $125,000 in monthly fees during 2025. The agreement terminated in March 2026.
• Common Stock Purchase Agreements: Agreements in November and December 2024 with Exicure HiTron Inc. and SangSangIn Investment & Securities Co., Ltd. for the issuance of shares at $3.00 and $4.61 per share, respectively.
• DGP Note: A $700,000 loan from DGP Co., Ltd. in June 2024, with interest, was converted into 237,223 shares of common stock in September 2024.
• CBI USA Private Placement: A private placement in February 2023 involved the issuance of shares at $8.00 per share. Liquidated damages of $27,000 were paid to CBI USA and $191,000 accrued to DGP due to delayed registration statement filing, though DGP later waived the penalty.
• Korea Lease: KC Creation executed a lease agreement with YOOSOO Co., Ltd (related to Exicure HiTron Inc.) for a space in Korea, requiring only a refundable security deposit and no lease payments.

Stakeholder Impact

• Shareholders: Potential for significant dilution from proposed share issuances and increased authorized shares. Also, potential for increased value if capital raised is used effectively for growth.
• Employees: The 2026 Omnibus Incentive Plan aims to attract, retain, and motivate employees by offering equity-based compensation.
• Management: May benefit from equity awards under the new plan, aligning their interests with shareholders. Also, subject to potential scrutiny due to recent leadership changes.
• Creditors: The company's ability to raise capital through financings could impact its ability to meet obligations.

Next Steps

• Stockholders will vote on the proposals at the 2026 Annual and Special Meeting of Stockholders on December 2, 2026.
• If approved, the company may proceed with private financing transactions within the three-month authorization period.
• If approved, the company may file the Certificate of Amendment to increase authorized shares.
• If approved, the 2026 Omnibus Equity Incentive Plan will be adopted.
• Final voting results will be published in a Form 8-K filing within four business days following the meeting.

Key Dates

Recommendation

The filing outlines standard annual meeting proposals, including necessary steps for future capital raising and employee incentives. However, the significant potential for dilution from the proposed share issuance and increased authorized shares, coupled with recent management turnover, warrants a cautious 'hold' stance until the impact of these actions becomes clearer.

Keywords

Annual Meeting, Special Meeting, Proxy Statement, Director Election, Equity Incentive Plan, Share Issuance, Authorized Shares, Auditor Ratification